Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

The biotech industry flourished amid the pandemic, and lucrative federal investments are expected to drive further growth in the sector. Moreover, amid evolving variants of Coronavirus, the biotech industry is expected to remain in the limelight. Given the sound prospects of the industry, quality biotech stocks Gilead Sciences (GILD) and…

StockNews.com

Tributes to Bristol Drugs Project pioneer Maggie Telfer, who has died at 63

"Maggie’s leadership, compassion and indomitable spirit inspired all around her"

Bristol Post

1 Large-Cap Stock You Should Purchase This Week

Pharmaceutical company Novartis (NVS) maintained its growth momentum in the third quarter of fiscal 2022, and the company’s growth prospects look promising, supported by its clear focus on five core therapeutic areas, having multiple significant in-market and pipeline assets. Given NVS’ reliable dividend payments and high profitability, this large-cap stock…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Safe consumption rooms progress has been too slow, says Scottish Labour

There has been little movement towards the roll-out of safe consumption rooms in the 14 months since the Lord Advocate confirmed there was a legal route to pursuing them.

Daily Record

Many workers barely recall signing noncompetes, until they try to change jobs

Employers say that noncompete agreements are needed to protect trade secrets and investments. The FTC says they deprive workers of their economic liberties and has proposed a rule to ban them.

WEKU

The US government spent $30bn developing the Covid vaccine. So how can Moderna plan to charge $110 a jab?

Vaccines were built in part on government research and funding, but treatment won’t be free to Americans much longer

The Independent UK

Bristol-Myers Squibb (BMY) is a Top Value Stock for 2023

The bear market has been downright brutal for growth stocks. Thus making it clear that now is the time for value. That is why you need to discover the attractiveness of Bristol-Myers Squibb (BMY) shares. Read on below for the full story.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

£68m plan to tackle Scotland's drug deaths emergency unveiled

THE Scottish Government has unveiled a £68 million package of measures aimed at tackling the country’s drug deaths crisis.

The National (Scotland)

Dublin pharmacist warns against stockpiling amid surge in demand for Calpol

Tomas Conefrey, who runs Conefrey's CarePlus Pharmacy on Pearse Street, says that panic purchases of Calpol and Nurofen are occurring in store

Dublin Live

The FDA no longer requires all drugs to be tested on animals before human trials

In a victory for animal rights advocates, drugmakers can take their products to human clinical trials using alternative testing methods that don't involve animals.

WEKU

As Dexcom Settles, 2 Option Strategies Collect Premium, Minimize Risk

Let's consider a combination of two strategies involving options with the goal being to collect as much premium upfront and minimizing our risk.

Investors Business Daily

Pharma lobby blasts 'stupid' pandemic patent plans

Geneva (AFP) - Stripping patent protection from Covid-19 treatments is a "mind-bogglingly stupid" idea, the head of a leading pharmaceutical lobby said Wednesday, warning that the move would put industry innovation at risk.

AFP

Vertex Pharmaceuticals Stock Sees Rising Relative Strength

A Relative Strength Rating upgrade for Vertex Pharmaceuticals shows improving technical performance. Will it continue?

Investors Business Daily

Local chemists suffering £67,000 annual shortfall, say pharmacists' leaders

The Company Chemists’ Association blasted the "truly broken" funding system and warned the Government that pharmacists needed extra cash to help ease the desperate NHS crisis

Daily Mirror

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

The No. 1 Stock to Keep an Eye on in 2023

Bristol-Myers Squibb Company (BMY) launched three first-in-class therapies across different disease areas last year. Moreover, the company is waiting for the FDA’s approval of repotrectinib this year. These new products are expected to drive the company’s long-term growth. So, it could be wise to keep an eye on BMY this…

Glasgow Live

Glasgow roll out of methadone alternative for heroin users steps up

Hundreds of peope in Glasgow who are battling heroin addiction are now receiving the drug on prescription, following year of record drugs deaths.

Evening Standard

Politics LIVE: Rishi Sunak accused by Keir Starmer at PMQs of ‘prolonging misery’ over strikes and going from ‘clapping to sacking’ nurses

Prime Minister Rishi Sunak was accused by Keir Starmer of choosing to “prolong the misery” over strikes at PMQs.

Caixin Global

Vaccine-Maker CanSino Bio Plans Swiss Listing

The company, which has developed multiple Covid-19 vaccines, aims to tap new international financing and boost its global brand

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Editorial: Delay in making naloxone an over-the-counter drug to counter opioid overdoses was deadly

It's been six years since a startling story in The New York Times detailed how fatal opioid overdoses were tearing through rural regions of the United States "like a plow through soil." The report came as the nation was beginning to grasp that it faced the deadliest wave of drug…

Investors Business Daily

IBD Stock Of The Day Medpace Flashes Buy Signal — Why You Should Be Cautious

Medpace Holdings is Tuesday's IBD Stock Of The Day as MEDP stock bounces off its 50-day line amid bullish fourth-quarter expectations.

Investors Business Daily

AstraZeneca Stock Nabs Brief Breakout After $1.8 Billion CinCor Buyout

AstraZeneca stock briefly broke out on Tuesday, a day after announcing its $1.8 billion plan to acquire CinCor.

The Independent UK

Rep. Katie Porter seeking Feinstein's Senate seat in 2024

Democratic Rep. Katie Porter of California says she will seek the U.S. Senate seat currently held by Sen. Dianne Feinstein, a fellow Democrat and the oldest member of the chamber

Investors Business Daily

Illumina's Woes Mount As Guidance Lags And Grail Controversy Continues

Illumina stock plunged to its lowest point in three months Tuesday after the gene-sequencing giant issued a disappointing outlook for 2023.

Caixin Global

Pfizer CEO Dismisses Reports of a Paxlovid Generic for China

The U.S. pharmaceutical giant is working on starting domestic production of the branded version of the Covid drug in the first half of this year

Los Angeles Times

Commentary: Abortion pills in pharmacies are the future. But the FDA should do more to expand access

On Jan. 3, the U.S. Food and Drug Administration took a first step toward making abortion pills available at retail pharmacies. It released new rules outlining how both bricks-and-mortar and mail-order pharmacies can get certified to dispense mifepristone, the first pill in a medication abortion. But the agency also left…

1 … 53 54 55 56

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Federal Trade Commission

147 stories

World Trade Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.